Newly identified drug target in rheumatoid arthritis paves the way for the development of new therapies

Aug 22, 2018

University of Melbourne researchers have identified a protein involved in rheumatoid arthritis-induced inflammation that could lead to new drug treatments for people who do not respond to current therapies.

Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.